OR WAIT null SECS
Jennifer Markarian is manufacturing editor of BioPharm International.
Supply-chain visibility systems are proving their worth in the distribution of COVID-19 vaccines and may see broader use in the future.
Now that COVID-19 vaccines have received regulatory authorizations and vaccine manufacturers are providing a steady and increasing supply, the focus is on distributing doses. Vaccine manufacturers worked closely with cold-chain distribution experts to plan for maintaining and monitoring the cold chain for these crucial drug products. Pharmaceutical Technology spoke with Mahesh Veerina, CEO of Cloudleaf, and Gisli Herjolfssonn, CEO and cofounder of Controlant, about supply-chain visibility systems for maintaining the cold chain.
Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.
eBook: Biologics and Sterile Drug Manufacturing, May 2021
When referring to this article, please cite it as J. Markarian, “Tracking Technologies Safeguard Vaccine Cold Chain" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).